Related Experiment Video
Updated: Jan 6, 2026

Evaluation of Amino Acid Consumption in Cultured Bone Cells and Isolated Bone Shafts
Published on: April 13, 2022
Dysregulation of glutaminase and glutamine synthetase in cancer
José M Matés1, José A Campos-Sandoval1, Juan de Los Santos-Jiménez1
1Department of Molecular Biology and Biochemistry, Canceromics Lab, Faculty of Sciences, Campus de Teatinos, University of Málaga, 29071, Málaga, Spain; Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain.
Abstract:
Besides fast glucose catabolism, many types of cancers are characterized by elevated glutamine consumption. Medical oncology pursuits to block specific pathways, mainly glycolysis and glutaminolysis, in tumor cells to arrest cancer development. This strategy frequently induces adaptive metabolic resistance that must be countered. Combination therapy is an anticancer synergistic tool to overcome both cancer growth and resistance mechanisms. Dysregulation of glutaminase and glutamine synthetase are key events that allow anabolic adaptation of tumors. Several specific drugs that inhibit metabolic enzymes dealing with glutamine metabolism have been able to eliminate some neoplasms. Targeting the tumor microenvironment can be also another essential factor to be taken into account when single or combined cancer metabolic therapy fails.
Insights
Cancer cells consume elevated glutamine, driving tumor growth. Combination therapies targeting glutamine metabolism and the tumor microenvironment are crucial for overcoming cancer resistance.
Area of Science:
- Oncology
- Cancer Metabolism
- Biochemistry
Background:
- Many cancers exhibit rapid glucose breakdown and increased glutamine uptake.
- Targeting cancer cell metabolism, particularly glycolysis and glutaminolysis, is a key medical oncology strategy.
- Tumor cells develop adaptive resistance to metabolic inhibitors, necessitating advanced therapeutic approaches.
Purpose of the Study:
- To explore the role of glutamine metabolism in cancer development and resistance.
- To evaluate combination therapies for overcoming cancer growth and metabolic resistance.
- To investigate the potential of targeting glutaminase, glutamine synthetase, and the tumor microenvironment.
Main Methods:
- Analysis of cancer cell metabolic pathways, focusing on glucose and glutamine.
- Review of therapeutic strategies involving inhibitors of glutamine metabolism enzymes (glutaminase, glutamine synthetase).
- Consideration of combination therapies and targeting the tumor microenvironment.
Main Results:
- Dysregulation of glutaminase and glutamine synthetase facilitates tumor anabolic adaptation.
- Specific drugs inhibiting glutamine metabolism enzymes have shown efficacy against certain neoplasms.
- Combination therapy presents a synergistic approach to combat cancer growth and resistance.
Conclusions:
- Targeting glutamine metabolism is essential for controlling cancer progression.
- Combination therapies and targeting the tumor microenvironment are vital for overcoming treatment resistance.
- Further research into metabolic pathway inhibition and combination strategies is warranted.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Biosynthesis of Nucleic Acids
Abnormal Proliferation
Mitogens and the Cell Cycle
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...

